April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Tesla: Rebound Signals Strength Amid Economic Shifts
3M: Evaluating Challenges to Portfolio Resilience
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
HCW Biologics (HCWB) stock forecast for 2026
Updated: April 20, 2025 (19:53)
Sector: HealthcareThe share price of HCW Biologics Inc. (HCWB) now
50/200 Day Moving Average: $12.97 / $18.35
This figure corresponds to the Average Price over the previous 50/200 days. For HCW Biologics stocks, the 50-day moving average is the resistance level today.
For HCW Biologics stocks, the 200-day moving average is the resistance level today.
Are you interested in HCW Biologics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the HCW Biologics stock price in 2026. How much will one HCW Biologics share be worth in 2026? Is it worth taking profit / loss on HCWB stock now or waiting? What are analysts' forecasts for HCW Biologics stock?
We forecast HCW Biologics stock performance using neural networks based on historical data on HCWB stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
HCW Biologics Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for HCW Biologics analysts is $120. Today 200 Day Moving Average is the resistance level (18.35 $). 50 Day Moving Average is the resistance level (12.97 $).
Historical and forecast chart of HCW Biologics Inc. stock
The chart below shows the historical price of HCW Biologics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the HCWB stock price can be found in the table below.
HCW Biologics (HCWB) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.79 | 5.26 | 6.04 | 12.90 % |
| Feb | 6.95 | 6.41 | 7.90 | 18.85 % |
| Mar | 5.81 | 5.02 | 6.78 | 25.94 % |
| Apr | 6.14 | 5.39 | 6.73 | 19.92 % |
| May | 6.54 | 5.74 | 7.63 | 24.68 % |
| Jun | 6.53 | 6.18 | 6.95 | 11.04 % |
| Jul | 7.86 | 6.59 | 8.50 | 22.52 % |
| Aug | 8.35 | 7.44 | 8.77 | 15.19 % |
| Sep | 8.60 | 7.35 | 9.99 | 26.39 % |
| Oct | 9.52 | 8.60 | 10.08 | 14.68 % |
| Nov | 10.28 | 8.55 | 10.88 | 21.42 % |
| Dec | 9.13 | 8.54 | 9.67 | 11.70 % |
HCW Biologics information and performance
2929 N COMMERCE PKWY, MIRAMAR, FL, US
Market capitalization of the HCW Biologics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HCWB shares in the company outstanding by the market price of one share.
EBITDA of HCW Biologics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
HCW Biologics price target for 2026 by month
Target values for the price of one HCW Biologics share for Jan 2026.
In Jan, the Negative dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 12.898% volatility is expected.
Pessimistic target level: 5.26
Optimistic target level: 6.04
Target values for the price of one HCW Biologics share for Feb 2026.
In Feb, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 18.847% volatility is expected.
Pessimistic target level: 6.41
Optimistic target level: 7.90
Target values for the price of one HCW Biologics share for Mar 2026.
In Mar, the Negative dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 25.937% volatility is expected.
Pessimistic target level: 5.02
Optimistic target level: 6.78
Target values for the price of one HCW Biologics share for Apr 2026.
In Apr, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 19.916% volatility is expected.
Pessimistic target level: 5.39
Optimistic target level: 6.73
Target values for the price of one HCW Biologics share for May 2026.
In May, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 24.676% volatility is expected.
Pessimistic target level: 5.74
Optimistic target level: 7.63
Target values for the price of one HCW Biologics share for Jun 2026.
In Jun, the Negative dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 11.041% volatility is expected.
Pessimistic target level: 6.18
Optimistic target level: 6.95
Target values for the price of one HCW Biologics share for Jul 2026.
In Jul, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 22.516% volatility is expected.
Pessimistic target level: 6.59
Optimistic target level: 8.50
Target values for the price of one HCW Biologics share for Aug 2026.
In Aug, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 15.194% volatility is expected.
Pessimistic target level: 7.44
Optimistic target level: 8.77
Target values for the price of one HCW Biologics share for Sep 2026.
In Sep, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 26.392% volatility is expected.
Pessimistic target level: 7.35
Optimistic target level: 9.99
Target values for the price of one HCW Biologics share for Oct 2026.
In Oct, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 14.677% volatility is expected.
Pessimistic target level: 8.60
Optimistic target level: 10.08
Target values for the price of one HCW Biologics share for Nov 2026.
In Nov, the Positive dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 21.421% volatility is expected.
Pessimistic target level: 8.55
Optimistic target level: 10.88
Target values for the price of one HCW Biologics share for Dec 2026.
In Dec, the Negative dynamics for HCW Biologics Inc. shares will prevail with possible monthly volatility of 11.702% volatility is expected.
Pessimistic target level: 8.54
Optimistic target level: 9.67
